When did NUVATION BIO INC (NUVB) report earnings last quarter?
NUVATION BIO INC (NUVB) last reported earnings on 3/2/2026.
NUVATION BIO INC (NUVB) Earnings History & Surprises
NYSE:NUVB • US67080N1019
Current stock price
4.85 USD
+0.15 (+3.19%)
At close:
4.8009 USD
-0.05 (-1.01%)
After Hours:
NUVB Earnings overview
Past quarterly earnings results for NUVATION BIO INC (NUVB), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 5, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.01
- Revenue Estimate
- 61.204M
Last Reported
Most Recent- Release Date
- Mar 2, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.11
- EPS Surprise
- -20.68%
- Revenue Surprise
- 9.96%
Beat Rate
Last 8 Quarters 25%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.11 | -0.09 | -20.68% | 26.67% | 41.865M | 38.073M | 9.96% | 633.06% |
| Q3 2025 | -0.16 | -0.17 | 6.98% | -6.67% | 13.12M | 6.746M | 94.49% | 1,704.68% |
| Q2 2025 | -0.17 | -0.17 | 0.88% | -13.33% | 4.833M | 364.283K | 1,226.72% | 236.79% |
| Q1 2025 | -0.16 | -0.16 | 0.90% | -128.57% | 3.084M | 425.003K | 625.64% | - |
| Q4 2024 | -0.15 | -0.14 | -6.56% | -150.00% | 5.711M | - | - | |
| Q3 2024 | -0.15 | -0.13 | -13.12% | -66.67% | 727K | - | - | |
| Q2 2024 | -0.15 | -0.06 | -151.38% | -66.67% | 1.435M | - | - | |
| Q1 2024 | -0.07 | -0.10 | 28.36% | 30.00% | - | - | ||
| Q4 2023 | -0.06 | -0.11 | 43.89% | 40.00% | - | - | ||
| Q3 2023 | -0.09 | -0.11 | 19.54% | 25.00% | - | - | ||
| Q2 2023 | -0.09 | -0.11 | 21.10% | 43.75% | - | - | ||
| Q1 2023 | -0.10 | -0.10 | 1.96% | - | - | - | ||
| Q4 2022 | -0.10 | -0.12 | 14.75% | 16.67% | - | - | ||
| Q3 2022 | -0.12 | -0.14 | 15.97% | -9.09% | - | - | ||
| Q2 2022 | -0.16 | -0.14 | -18.07% | -77.78% | - | - | ||
| Q1 2022 | -0.10 | -0.15 | 31.92% | 16.67% | - | - | ||
| Q4 2021 | -0.12 | -0.12 | 0.58% | -152.08% | - | - | ||
| Q3 2021 | -0.11 | -0.11 | -1.74% | - | - | - | ||
| Q2 2021 | -0.09 | -0.10 | 9.96% | - | - | - | ||
| Q1 2021 | -0.12 | -0.07 | -68.07% | - | - | - | ||
| Q4 2020 | -0.05 | - | - | - | - | |||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
-2.98%
Max EPS beat (4)
6.98%
Min EPS beat (4)
-20.68%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
489.20%
Max Revenue beat (4)
1,226.72%
Min Revenue beat (4)
9.96%
Analysis
In the last 4 quarters, NUVB has beaten EPS estimates in 3 out of 4 releases
NUVB has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, NUVB reported -3.0% below the EPS estimates on average.
In the last 4 quarters, NUVB has beaten the revenue estimates by 489.2% on average.
Related analysis
NUVATION BIO INC / NUVB Earnings FAQ
Can you provide information on whether NUVATION BIO INC beat earnings estimates in the last quarter?
NUVATION BIO INC (NUVB) missed EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often NUVATION BIO INC beats earnings estimates?
In the last 4 quarters, NUVATION BIO INC (NUVB) has beaten EPS estimates in 3 out of 4 releases.